TMCI:NASDAQ
Treace Medical Concepts, Inc
US$4.31
arrow_downward
-0.92%(-0.040) 1D
US$4.31
0.00% (0.00)
bedtimeAfter hours
Closed: ኖቬም 20, 4:00:01 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
US$4.31
High
US$4.43
Low
US$4.17
Mkt. cap
282.56 ሚ
Avg. vol.
288.65 ሺ
Volume
232.75 ሺ
52-wk high
US$5.43
52-wk low
US$1.17
EPS
-US$0.86
Beta
1.59
Shares outstanding
65.56 ሚ
No. of employees
450
Open
US$4.31
High
US$4.43
Low
US$4.17
Mkt. cap
282.56 ሚ
Avg. vol.
288.65 ሺ
Volume
232.75 ሺ
52-wk high
US$5.43
52-wk low
US$1.17
EPS
-US$0.86
Beta
1.59
Shares outstanding
65.56 ሚ
No. of employees
450
News stories
From web sources and news partners
AP News
·
ከ1 ሰዓት በፊት
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
WSJ
·
ከ13 ሰዓቶች በፊት
S&P 500 Flirts With Correction
Los Angeles Times
·
ከ6 ሰዓቶች በፊት
S&P 500 falls 10% from record, entering correction as AI trade unravels
Yahoo Finance
·
ከ5 ሰዓቶች በፊት
Dow and S&P 500 Plunge Into Correction as Tech Selloff Deepens
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc